Kiora Pharmaceuticals (KPRX) Receivables - Net (2017 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Receivables - Net came in at $1.5 million in Q1 2026, up 15.45% YoY from $1.3 million in Q1 2025, and up 1.41% on a QoQ basis from $1.5 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Receivables - Net (2017 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 5 years of Receivables - Net data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Receivables - Net rose 15.45% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 15.45% YoY) and the FY2025 annual result came in at $1.5 million, up 153.29% from the prior year.
- Receivables - Net improved to $1.5 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $2.4 million in Q2 2025 to a low of $189905.0 in Q1 2024.
- A 3-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Receivables - Net.
- The widest YoY moves for Receivables - Net: up 604.35% in 2025, down 31.97% in 2025.
- Tracing KPRX's Receivables - Net over 3 years: stood at $601197.0 in 2024, then surged by 153.29% to $1.5 million in 2025, then rose by 1.41% to $1.5 million in 2026.
- The last three Receivables - Net figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 2.42 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 601,197.00 |
| Dec 31, 2024 | 601,197.00 |
| Sep 30, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 189,905.00 |
| Mar 31, 2024 | 189,905.00 |